Methods of preventing or treating T cell malignancies by administering CD2 antagonists

Details for Australian Patent Application No. 2010200956 (hide)

Owner National Cancer Institute MedImmune, LLC.

Inventors Dingivan, Christine; Waldmann, Thomas

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010200956

Parent 2003273299

Filing date 12 March 2010

Wipo publication date 1 April 2010

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

25 March 2010 Complete Application Filed

1 April 2010 Application Open to Public Inspection

  Published as AU-A-2010200956

4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010200957-System and method for communicating data in locomotive consist or other vehicle consist

2010200955-Detection of human papillomavirus